NASDAQ · ALGS

Aligos Therapeutics, Inc.

Closing price · Nov 13, 2026 $2.10

Latest quarter · ended Sep 30, 2026

Sales grew and cash improved

descriptionFiled Nov 6, 2026
Revenue growthFaster
+281.9%
Quarter ended Dec 31, 2024: −9.8% sales vs. a year beforeQuarter ended Mar 31, 2025: −55.2% sales vs. a year beforeQuarter ended Jun 30, 2025: −9.0% sales vs. a year beforeQuarter ended Sep 30, 2025: −40.7% sales vs. a year beforeQuarter ended Dec 31, 2025: −72.1% sales vs. a year beforeQuarter ended Mar 31, 2026: +810.0% sales vs. a year beforeQuarter ended Jun 30, 2026: −100.0% sales vs. a year beforeQuarter ended Sep 30, 2026: +281.9% sales vs. a year before
Dec '24Sep '26
$2.83M vs. $741K a year ago
Cash from operationsBetter
$1.45M
Quarter ended Dec 31, 2024: −$18.4M cash from operationsQuarter ended Mar 31, 2025: −$20.9M cash from operationsQuarter ended Jun 30, 2025: −$15.5M cash from operationsQuarter ended Sep 30, 2025: −$24.3M cash from operationsQuarter ended Dec 31, 2025: −$21.7M cash from operationsQuarter ended Mar 31, 2026: −$23.1M cash from operationsQuarter ended Jun 30, 2026: −$24.9M cash from operationsQuarter ended Sep 30, 2026: $1.45M cash from operations
Dec '24Sep '26
vs. −$24.3M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

31 funds report owning ALGS, down from 33

Holdings as of Jun 30, 2026
New6
Added6
Held14
Trimmed5
Sold out8

Insider trades · last 12 months

Real buys and sales

No insider filings loaded for the last 12 months.

Top holders

Biggest funds in ALGS

As of Jun 30, 2026
FundValueChange
Deep Track Capital, LP$2.56MSame
Alyeska Investment Group, L.P.$2.38MSame
Sio Capital Management, LLC$1.89MSame
Marshall Wace, LLP$1.42M−8%
Woodline Partners LP$1.02MSame

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast